The Lawyer's Daily is now Law360 Canada. Click here to learn more.

Drug pricing review board orders manufacturer to lower prices on kidney medicine

Wednesday, September 28, 2022 @ 5:28 PM | By Terry Davidson

Canada’s drug pricing watchdog has ordered a pharmaceutical company to lower its prices on a medicine used to treat a genetic disorder that harms kidney function.  ...